Optibiotix Health Plc
(the "Company" or the "Group")
Investor Teach-In
OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes announces it will be holding a teach-in for investors and analysts on Wednesday, 18th March 2015.
The event will be held in the Black Bar, upstairs at Rocket Bar, 6 Adams Court, Old Broad Street, London EC2N 1DX from 4.30pm.
A presentation will be given founder & CEO of OptiBiotix, Stephen O'Hara, for approximately one hour. The presentation will include an overview of the Company and an outline of their strategy to deliver value for shareholders. This will be followed by light refreshments and an opportunity to network.
To register for the event, please email optibiotix@walbrookpr.com or call the Walbrook PR team below.
OptiBiotix Health plc |
|
Stephen O'Hara, Chief Executive |
Contact via Walbrook below |
|
|
Cairn Financial Advisers LLP |
Tel: 020 7148 7900 |
Liam Murray / Avi Robinson |
|
|
|
Hybridan LLP (Joint Broker) Claire Louise Noyce
|
Tel: 020 3713 4581 |
Peterhouse Corporate Finance Ltd (Joint Broker) |
Tel: 020 7469 0936 |
Lucy Williams / Duncan Vasey |
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or optibiotix@walbrookpr.com |
Anna Dunphy |
Mob: 07876 741 001 |
Mike Wort |
Mob: 07900 608 002 |